Related Experiment Video
Updated: Jun 17, 2026

07:20
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Naphthalimide gold(I) phosphine complexes as anticancer metallodrugs
Christoph P Bagowski1, Ya You, Heike Scheffler
1Department of Integrative Zoology, Institute of Biology, University of Leiden, 2333 AL Leiden, The Netherlands.
Dalton Transactions (Cambridge, England : 2003)
|December 22, 2009
Summary
New gold(I) phosphine complexes with naphthalimide ligands show strong anticancer activity and antiangiogenic effects. These compounds increase cellular gold uptake and exhibit promising potential for cancer drug development.
Area of Science:
- Medicinal Chemistry
- Inorganic Chemistry
- Cancer Biology
Background:
- Gold(I) phosphine complexes are investigated for anticancer applications.
- Naphthalimide ligands can be incorporated into metal complexes for therapeutic purposes.
Purpose of the Study:
- To synthesize and evaluate novel gold(I) phosphine complexes featuring a naphthalimide ligand for anticancer activity.
- To investigate the cellular uptake, localization, and antiangiogenic properties of these complexes.
Main Methods:
- Synthesis of gold(I) phosphine complexes with naphthalimide ligands.
- Antiproliferative assays using MCF-7 breast cancer and HT-29 colon carcinoma cell lines.
- Cellular and nuclear gold level quantification.
- Biochemical and biological studies including fluorescence emission, cellular uptake, and in vivo zebrafish angiogenesis models.
Main Results:
- The synthesized gold(I) phosphine complexes demonstrated potent antiproliferative effects against breast and colon cancer cells.
- Complexes with naphthalimide ligands showed higher cellular and nuclear gold accumulation compared to chloro analogues.
- Compound 4a exhibited solvent-dependent fluorescence, efficient tumor cell organelle uptake, and significant antiangiogenic effects in zebrafish models.
Conclusions:
- Gold(I) phosphine complexes with naphthalimide ligands represent a promising class of anticancer agents.
- The observed antiangiogenic properties of compound 4a warrant further investigation for therapeutic potential in cancer treatment.

